Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |